Enzyme-Linked Immunosorbent Spot Assay for Donor-Reactive Interferon-Gamma-Producing Cells Identifies T-Cell Presensitization and Correlates with Graft Function at 6 and 12 Months in Renal-Transplant Recipients
- 15 December 2004
- journal article
- research article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 78 (11) , 1640-1646
- https://doi.org/10.1097/01.tp.0000144057.31799.6a
Abstract
Background. A major goal in clinical transplantation is the individualization of immunosuppression. This requires a definition of markers that identify patients at heightened risk of acute rejection and immune-mediated chronic allograft nephropathy. Methods. Frequencies of interferon–γ-producing donor-reactive cells were serially determined in unselected renal-transplant patients in an enzyme-linked immunosorbent spot assay (ELISPOT) before transplantation (n=42) and up to 10 (mean 5.0) times during the first 6 months posttransplantation (n=48) to determine detailed kinetics and analyze for correlation with acute rejection and graft function at 6 and 12 months posttransplantation. Results. Pretransplant ELISPOT frequencies were significantly higher in patients with acute rejection (16/42) versus nonrejecters (26/42). Highly elevated pretransplant frequencies (>200 spots/300,000 peripheral blood mononuclear cells [PBMCs], n=5/42) were associated with a risk of severe acute rejection episodes but were independent of risk factors such as high panel reactive antibodies. Early graft failure exclusively occurred in this group. Importantly, mean ELISPOT frequencies at weeks 2 and 3 but not at month 6 posttransplant correlated inversely with 6 and 12 months glomerular filtration rate. The correlation between ELISPOT frequencies and renal function showed the highest significance in patients without acute rejection. Conclusions. The pretransplant ELISPOT assay might be useful to identify T-cell presensitized patients, who are at heightened risk for severe early acute rejection. An analysis of ELISPOT donor-reactive cells during the early posttransplant period might allow an identification of patients at risk for immune-mediated graft deterioration.Keywords
This publication has 24 references indexed in Scilit:
- Enzyme Linked Immunosorbent Spot (ELISPOT) Assay for Interferon‐Gamma Independently Predicts Renal Function in Kidney Transplant RecipientsAmerican Journal of Transplantation, 2003
- Pathogenesis of chronic allograft rejectionTransplant International, 2003
- Kidney graft failure and presensitization against HLA Class I and Class II antigens1Transplantation, 2002
- Strategies to Improve Long-Term Outcomes after Renal TransplantationNew England Journal of Medicine, 2002
- Enzyme-Linked Immunosorbent Spot (ELISPOT) Assay for Detection of Alloreactive Cytokine-Reacting Cells—Detailed MethodsGraft, 2001
- High frequency of IL-4 producing helper T lymphocytes associated with a reduced incidence of heart allograft rejectionTransplant International, 2000
- Lack of correlation of MLC reactivity with acute graft-versus-host disease and mortality in unrelated donor bone marrow transplantationHuman Immunology, 1996
- Complete subtyping of the HLA‐A locus by sequence‐specific amplification followed by direct sequencing or single‐strand conformation polymorphism analysisTissue Antigens, 1995
- HLA‐DR typing by PCR amplification with sequence‐specific primers (PCR‐SSP) in 2 hours: An alternative to serological DR typing in clinical practice including donor‐recipient matching in cadaveric transplantationTissue Antigens, 1992
- Cellular requirements for renal allograft rejection in the athymic nude rat.The Journal of Experimental Medicine, 1989